Sol-Gel Technologies Ltd.

Is Sol-Gel Technologies Ltd. overvalued or undervalued?

As of March 10, 2023, Sol-Gel Technologies Ltd. is considered overvalued and has shifted from a fair to a risky valuation grade due to poor financial metrics, including negative returns and a high EV to EBITDA ratio compared to its peers.

As of 10 March 2023, the valuation grade for Sol-Gel Technologies Ltd. moved from fair to risky, indicating a shift towards a more negative outlook. The company appears to be overvalued given its financial metrics, particularly with a Price to Book Value of 1.00 and an EV to Sales ratio of 0.30, which suggest limited growth potential in relation to its market price. Additionally, the company's negative ROCE of -388.12% and ROE of -64.66% further highlight its struggles in generating returns for shareholders.<BR><BR>In comparison to its peers, Sol-Gel Technologies Ltd. has a significantly higher EV to EBITDA ratio of -11.1084 compared to Assembly Biosciences, Inc. at -6.6467 and Societal CDMO, Inc. at 18.7985, indicating that it is not performing well relative to its industry counterparts. The overall financial health and performance metrics suggest that the company is overvalued in the current market context. There is no available return data to compare against the S&P 500, but the lack of positive returns reinforces the concerns surrounding its valuation.

Is Sol-Gel Technologies Ltd. technically bullish or bearish?

As of September 4, 2025, Sol-Gel Technologies Ltd. shows a bullish trend with strong momentum indicators, despite a bearish monthly RSI and mildly bearish weekly OBV, while significantly outperforming the S&P 500 year-to-date and over the past year.

As of 4 September 2025, the technical trend for Sol-Gel Technologies Ltd. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, indicating positive momentum. However, the monthly RSI is bearish, suggesting some weakness in price strength. The daily moving averages are bullish, supporting the overall positive outlook. Despite the bullish trend, the weekly OBV is mildly bearish, which could indicate some selling pressure. <BR><BR>In terms of performance, the stock has significantly outperformed the S&P 500 across multiple periods, with a year-to-date return of 185.64% compared to the S&P 500's 12.22%, and a one-year return of 310.25% versus 17.14%. Overall, the current technical stance is bullish, with strong momentum indicators but some caution due to the bearish monthly RSI.

How big is Sol-Gel Technologies Ltd.?

As of Jun 18, Sol-Gel Technologies Ltd. has a market capitalization of 19.51 million, with net sales of 12.10 million and a net profit of -13.05 million over the latest four quarters. Shareholder's funds are 28.85 million, and total assets are 35.85 million.

As of Jun 18, Sol-Gel Technologies Ltd. has a market capitalization of 19.51 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 12.10 million, while the sum of Net Profit for the same period is -13.05 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 28.85 million and Total Assets at 35.85 million.

What does Sol-Gel Technologies Ltd. do?

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company focused on developing topical drug products for skin diseases. As of March 2025, it has a market cap of $19.51 million, with net sales of $1 million and a net loss of $9 million.

Overview: <BR>Sol-Gel Technologies Ltd. is a clinical-stage dermatology company focused on developing and commercializing branded and generic topical drug products for the treatment of skin diseases, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Sales: 1 Million (Quarterly Results - Mar 2025) <BR>Net Profit: -9 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 19.51 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.82 <BR>Return on Equity: -64.66% <BR>Price to Book: 0.97<BR><BR>Contact Details: <BR>Address: Weizmann Science Park, 7, Golda Me'ir, NESS-ZIONA None: 7403650 <BR>Tel: ['972 8 9313433'] <BR>Fax: 972 8 9313434 <BR>Website: http://www.sol-gel.com

Who are in the management team of Sol-Gel Technologies Ltd.?

As of March 2022, the management team of Sol-Gel Technologies Ltd. includes Chairman Mr. Moshe Arkin, CEO Dr. Alon Seri-Levy, Directors Mr. Itai Arkin, Ms. Hani Lerman, and independent Directors Dr. Shmuel Ben Zvi, Mr. Jerrold Gattegno, and Mr. Ran Gottfried. This diverse team oversees the company's governance and strategic direction.

As of March 2022, the management team of Sol-Gel Technologies Ltd. includes the following individuals:<BR><BR>- Mr. Moshe Arkin, Chairman of the Board<BR>- Dr. Alon Seri-Levy, Chief Executive Officer, Co-Founder, and Director<BR>- Mr. Itai Arkin, Director<BR>- Ms. Hani Lerman, Director<BR>- Dr. Shmuel Ben Zvi, Independent Director<BR>- Mr. Jerrold Gattegno, Independent Director<BR>- Mr. Ran Gottfried, Independent Director<BR><BR>This team comprises a mix of leadership roles and independent directors, contributing to the governance and strategic direction of the company.

Should I buy, sell or hold Sol-Gel Technologies Ltd.?